Corcept Therapeutics Stock Price (NASDAQ:CORT)

Add to My Stocks
$14.22 $0.04 (0.28%) CORT stock closing price Sep 19, 2018 (Closing)
Prev Close* : $14.26
Market Cap:
$1.65B
Day Low: $14.15
52 Week Low: $11.55
Open: $14.29
Volume: -
Day High: $14.71
52 Week High: $25.96
Dividend:
0.00

Latest Stock Market News

Latest Articles

Corcept Therapeutics News - From Partners

CORT Stockcharts

View CORT PE ratio, PS ratio stocks charts and compare with peers.
CORT Chart
Note: Compare Corcept Therapeutics stock price history with the index and industry peers.

Corcept Therapeutics Valuation

PE ratio
(price earnings ratio)
12.26
PS ratio (
price to sales ratio
)
7.6
PB ratio (
price to book ratio
)
10.24

Corcept Therapeutics Returns

ROE
(return on equity)
92%

Corcept Therapeutics Financial Ratios

Asset Turnover
0.96
Receivables Turnover
11.31
Debt to Equity
0
Dividend Yield
0%

CORT Industry Peers

Company Price Change (%)
Zogenix (ZGNX)47.051.6 (3.29%)
Enanta Pharma (ENTA)92.091.16 (1.28%)
Alder Biopharma (ALDR)15.950.4 (2.45%)
Viking Therapeutics (VKTX)19.650.19 (0.98%)
Cyclacel (CYCC)1.390.05 (3.47%)
Pfizer (PFE)43.260.25 (0.57%)
Lexicon Pharma (LXRX)10.750.23 (2.09%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
MOLECULAR TEMPL (MTEM)6.252.15 (52.44%)
Neptune Tech. & Bio. (NEPT)4.710.44 (10.3%)
Infinity Pharma (INFI)2.310.18 (8.45%)
Pacira Pharma (PCRX)51.353.5 (7.31%)
Aratana Therapeutics (PETX)5.840.39 (7.16%)
Achaogen (AKAO)4.560.28 (6.54%)
La Jolla Pharma (LJPC)22.071.12 (5.35%)
Top gainers from Medical-Drugs industry
* As of Sep 20, 2018
CompanyPriceChange (%)
PTC Therapeutics (PTCT)45.371.82 (3.86%)
USANA Health Sciences (USNA)119.354.75 (3.83%)
Esperion Therapeutics (ESPR)45.571.69 (3.58%)
ArQule (ARQL)4.850.17 (3.39%)
Zogenix (ZGNX)47.051.6 (3.29%)
Nektar Therapeutics (NKTR)56.691.64 (2.81%)
Durect (DRRX)1.10.03 (2.65%)
Top losers from Medical-Drugs industry
* As of Sep 20, 2018

Corcept Therapeutics Incorporated Stock News - Partner Headlines

3 Stocks to Sell Friday   on Aug 10, 2018

Corcept Therapeutics Financial Statements

income statement20172016201520142013
Net Sales or Revenues159.2M81.32M50.28M26.55M10.35M
Net Income129.12M8.14M-6.4M-31.38M-46.01M
Total Operating Expense102.78M69.08M52.35M53.28M51.71M
View Corcept Therapeutics income statement
balance sheet20172016201520142013
Total Assets220.53M68.75M51.93M34.63M63.07M
Total Liabilities29.56M27.37M33.43M38.01M42.06M
Shareholders Equity190.96M41.37M18.49M-3.38M21.01M
View Corcept Therapeutics balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-5.71M1.15M--5.04M-0.76M
Net Cash from (used by) Operating Activities60.93M18.39M3.13M-27.37M-37.05M
Increase (Decrease) in Prop Plant And Equipment-0.41M-0.19M-0.01M-0.17M-0.12M
View Corcept Therapeutics cash flow statement

Corcept Therapeutics Stock Message Board

Corcept Therapeutics stock lost 0.28%, and the last close price as of Sep 19, 2018 is $14.22 for CORT stock. The total market value as denoted by $1.65B for Corcept Therapeutics, is the market value of the company's outstanding shares. Corcept Therapeutics valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

The terms stocks and shares mean the same thing. For Ex: Corcept Therapeutics stock price and Corcept Therapeutics share price mean the same thing. The volume of shares traded stood at 898,744 on the last trading day, as is evident from Corcept Therapeutics stock chart, and CORT stock quote data. The board of directors decide what percentage of a company's earnings will be paid out as dividends. Corcept Therapeutics stock dividend was 0.00 during the last quarter. To check the historical stock price movement, all time high, and all time low of CORT, view Corcept Therapeutics stock price history.